Drug intelligence / Profile preview

Cal 216

Development stage
Unknown
Lead developer
Sugen Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Cal 216 is a branded generic combination product marketed by Sugen Pharma, primarily in the Indian market. It is formulated as a nutritional supplement to support bone health and address calcium deficiencies. The product typically contains a combination of calcium citrate, vitamin D3 (cholecalciferol), magnesium hydroxide, and zinc sulfate. Calcium citrate provides a bioavailable source of calcium essential for bone mineralization, while vitamin D3 acts as an agonist at the vitamin D receptor (VDR) to enhance intestinal calcium absorption. Magnesium and zinc are included as essential co-factors for bone metabolism and overall physiological support. Cal 216 is commonly indicated for the prevention and treatment of osteoporosis, osteomalacia, and hypocalcemia, and is frequently used as a supplement during pregnancy and lactation to meet increased mineral demands.

Brand names
Cal 216Cal216Cal-216
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Cal 216.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cal 216.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call